Journal of Clinical and Translational Hepatology

Journal of Clinical and Translational Hepatology

Saturday, 10 / 16 / 2021

Abstract

Clinical Advances in Fibrosis Progression of Chronic Hepatitis B and C

Ye-Jiao Wu, Ming-Yi Xu and Lun-Gen Lu*

Department of Gastroenterology, Shanghai First People’s Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China

Abstract

Chronic liver diseases, such as chronic hepatitis B (CHB) and chronic hepatitis C (CHC), are characterized by the presence of liver fibrosis, which may ultimately lead to cirrhosis. The progression of fibrosis is associated with various factors. Here, we review recent advances in the study of factors related to the progression rate of CHB- and CHC-induced fibrosis. Identification of these factors and establishment of a scoring system for cirrhosis risk are particularly important for predicting cirrhosis development, planning individualized treatment, and preventing fibrosis progression.

Doi: 10.14218/JCTH.2014.00029
Journal of Clinical and Translational Hepatology 2014 vol. 2 Pages: 222-227 
[PDF Full-text ]

 logo